Picture of BioXcel Therapeutics logo

BTAIQ — BioXcel Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

BioXcel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

* BioXcel Therapeutics Inc  BTAI.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-1.83.  The mean expectation of six analysts
for the quarter was for a loss of 71 cents per share. Wall
Street expected results to range from -79 cents to -54 cents per
share.
    * Revenue rose 141.6% to $1.10 million from a year ago;
analysts
expected $759.20 thousand. 
    * BioXcel Therapeutics Inc's reported EPS for the quarter
was a
loss of 21 cents​.
    * The company reported a quarterly loss of $8.3 million.
    * BioXcel Therapeutics Inc shares had fallen by 28.1% this
quarter and lost 68.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for BioXcel
Therapeutics Inc is $7.00 
This summary was machine generated from LSEG data August 6 at
01:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.71          -0.21          Beat
 Mar. 31 2024      -0.70          -0.87          Missed
 Dec. 31 2023      -0.91          -0.76          Beat
 Sep. 30 2023      -1.30          -1.72          Missed

Recent news on BioXcel Therapeutics

See all news